Cancer remains one of the leading causes of death and illness worldwide. In the USA alone, an estimated 2 million cancers and over 600,000 cancer deaths are predicted for 2025 according to the American Cancer Society (ACS). With all these types of tumors and due to the revolution that Oncology Resources is experiencing, HCPs need to be equipped with good, solid, evidence-based information. It is as crucial for planning and treatment as it is for patient education and care coordination over a prolonged period.
The goal is to educate HCPs about the most relevant oncology tools for every primary Tumor Types site. The article focuses on evidence-based tools, practice guides, registries, and educational resources to help professionals remain current in practice and give optimal care.
1. Breast Cancer
Summary: The most commonly diagnosed cancer among women in America, apart from skin cancers, is breast cancer. The American Cancer Society estimates 310,720 invasive breast cancer cases among women in 2025.
Core Resources
- National Comprehensive Cancer Network (NCCN) Guidelines: Offers up-to-date evidence-based treatment regimens for breast cancer subtypes such as hormone receptor-positive, HER2-positive, and triple-negative breast cancers.
- American Society of Clinical Oncology (ASCO): The clinical ASCO guidelines help treat early-stage to metastatic breast cancer and incorporate newer therapies, including antibody-drug conjugates and CDK4/6 inhibitors.
- SEER (Surveillance, Epidemiology, and End Results Program): SEER is operated by the National Cancer Institute (NCI) and provides detailed statistical data on breast cancer incidence and trends as well as survival.
- Breast: An NCI-supported platform for matching patients to appropriate clinical trials according to tumor profiles.
2. 2. Lung Cancer
Summary: Lung cancer is still among the leading cancer killers in women and men. According to estimates by the Centers for Disease Control and Prevention, over 127,000 people died from lung cancer in 2025, and 85% of them were due to non-small cell lung cancer (NSCLC).
Principal Sources
- NCCN Guidelines for Non-Small: Provides guideline-directed pathways for NSCLC and small-cell lung cancer (SCLC) with EGFR, ALK, ROS1, and KRAS mutation molecular testing.
- International Association for the Study of Lung Cancer: Offers access to worldwide staging guidelines, educational webinars, and a peer-reviewed journal focusing on thoracic oncology.
- National Lung Screening Trial (NLST): Published by the National Institutes of Health (NIH), this milestone trial advocates low-dose CT screening for reducing lung cancer mortality among high-risk patients.
- Lung Cancer Mutation Consortium (LCMC): An initiative that enables genomic testing and research through targeted therapies.
3. Colorectal cancer
Summary: Colorectal cancer is the third in cancer among cancers for Americans, but is highly preventable through screening. Colorectal cancer, according to CDC data, causes about 50,000 deaths each year.
- Core Resources: USPSTF Screening Recommendations The American Cancer Society and the USPSTF recommend screening for colorectal cancer to start at age 45.
- NCCN Practice Guidelines for Colon and Rectal Cancers: It entails surgical, chemotherapeutic, and targeted therapy schedules and follow-up regimens.
- Fight Colorectal Cancer (Fight CRC): Provides ongoing medical education (CME), policy, and resources for clinicians and patients alike.
- Colorectal Cancer Alliance: Provides HCPs with risk assessment tools, genetic counseling, and support services for patients.
4. Prostate Cancer
Summary: Prostate cancer is the second most common cancer in men. The ACS estimates over 288,000 new prostate cancers and 35,000 cancer deaths in the United States in 2025.
Key Resources
- NCCN Prostate Cancer Guidelines: Describes active surveillance, surgery, radiation therapy, and systemic therapy, stratified by risk groups.
- Prostate Cancer Foundation (PCF): Offers up-to-date research, biomarkers, and trial registries to HCPs with a focus on precision medicine.
- Urology Care Foundation: Comprises HCP-focused tools such as prostate-specific antigen screening decision aids and localized disease management decision aids.
- VA Health System Clinical Guidelines: The Department of Veterans Affairs has prostate cancer treatment pathways unique to veteran populations.
5. Hematologic M
Summary: Leukemia, lymphoma, and myeloma all qualify as blood cancers. The Leukemia & Lymphoma Society estimates that over 187,000 hematologic malignancies will be newly diagnosed in 2025 in the USA alone.
Major Resources
- ASH (American Society of Hematology): Produces high-impact clinical guidelines and sponsors yearly conferences featuring cutting-edge studies.
- NCCN Guidelines for Hematologic Cancers: In-depth treatment programs for acute leukemias and chronic leukemias, as well as for Hodgkin and non-Hodgkin lymphomas
- National Marrow Donor Program (Be The Match): Presents clinical data regarding stem cell transplantation, donor matching, and graft-versus-host disease management.
- CAR-T therapy registries: Supported by a grant from the Center for International Blood and Marrow Transplant Research (CIBMTR) for the collection of real-world outcome data on immunotherapies.
6. Gynecologic C
Summary: Gynecologic cancers include cancers in the ovaries, cervix, uterus, vulva, and vagina. According to the CDC, almost 94,000 women receive a diagnosis each year with gynecologic cancer in the United States.
Principal Sources
- SGO (Society of Gynecologic Oncology): Provides updates in clinical practice and treatment algorithms and fellowship training.
- NCCN Guidelines for Gynecologic Cancers. It covers cervical, endometrial, and ovarian cancer and their treatments using surgery, chemotherapy, and immunotherapy.
- CDC’s Inside Knowledge Campaign: Patient and provider educational materials on early symptoms and signs.
- The GOG Foundation (Gynecologic Oncology Group) encourages clinical trials and translational research in gynecologic cancers.
7. Skin Cancer (including Melanoma)
Explanation: The most common form of cancer in the United States is skin cancer, and melanoma is responsible for most skin cancer fatalities. The ACS projects over 100,000 melanoma diagnoses in 2025.
- Core Resources American Academy of Dermatology (AAD): Offers clinical guidelines and CME on skin cancer screening and dermoscopy